# Introduction
# Background
## Genetic Basis of Leber Congenital Amaurosis
## History of Gene Therapy
# The Breakthrough
## Overview of the Therapy
### Genetic Mechanism
### Development of the Viral Vectors
## Clinical Trials
### Phase I
### Phase II
### Phase III
## FDA Approval Process
# Patient Experiences
## Before Therapy
### Quality of Life
### Societal Challenges
## After Therapy
### Improvements in Vision
### Changes in Daily Life
# Implications for Future Research
## Other Genetic Disorders
## Technological Innovations
# Ethical and Safety Considerations
## Ethical Debate
## Safety Profile
## Long-term Effects
# Public and Scientific Reception
## Patient Advocacy Groups
## Healthcare Professionals
## Academic Community
# Future Directions
## Other Potential Treatments
## Policy and Funding